Recombinant Human Protein disulfide-isomerase protein (P4HB), partial (Active)

Shipped with Ice Packs
In Stock

Description

Clinical and Research Significance

Disease Associations

  • Neurodegenerative Diseases: Elevated nitrosylated P4HB correlates with Parkinson’s, Alzheimer’s, and ALS .

  • Glioblastoma (GBM): Maintains stemness in glioblastoma stem cells (GSCs) via Wnt/β-catenin signaling. Silencing P4HB reduces tumor growth and enhances chemosensitivity to temozolomide .

  • Cole-Carpenter Syndrome: Heterozygous P4HB mutations cause bone fragility .

Therapeutic Potential

TargetMechanismOutcome
GlioblastomaInhibition via CCF624 or securinineProlonged survival in xenograft models
Protein MisfoldingChaperone inhibitionReduced aggregation of misfolded proteins
Drug ResistanceER stress modulationEnhanced temozolomide efficacy

Experimental Applications

4.1 Protein Folding Studies
P4HB accelerates oxidative folding of nascent proteins and corrects misfolded disulfide bonds in vitro .

Biomarker Potential

  • GBM Diagnosis: Elevated serum P4HB correlates with disease progression .

  • Therapeutic Monitoring: P4HB levels predict treatment response in GBM .

Technical Considerations

  • Storage: Lyophilized at -20°C to -70°C; reconstituted aliquots stored at 2–8°C .

  • Handling: Avoid freeze-thaw cycles; use BSA as a stabilizer for long-term storage .

Research Findings and Mechanisms

5.1 Wnt/β-Catenin Signaling
P4HB activates Wnt/β-catenin in GSCs, upregulating stemness markers (SOX2, CD44) and oncogenic factors (Cyclin D1) . Inhibition with ICG001 suppresses these effects .

5.2 Redox Modulation
Interaction with LGALS9 enhances disulfide reductase activity at the T-cell surface, promoting migration and altering membrane redox states .

Product Specs

Buffer
0.2 µm filtered PBS, pH 7.0, lyophilized
Form
Liquid or Lyophilized powder
Lead Time
5-10 business days
Shelf Life
The shelf life is influenced by multiple factors, including storage state, buffer ingredients, storage temperature, and the protein's inherent stability. Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms typically maintain their stability for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is recommended for multiple use. Avoid repeated freeze-thaw cycles.
Tag Info
N-terminal 6xHis-tagged
Synonyms
Cellular thyroid hormone binding protein; Cellular thyroid hormone-binding protein; Collagen prolyl 4 hydroxylase beta; Disulphide Isomerase; DSI; EC 5.3.4.1; Endoplasmic reticulum resident protein 59; ER protein 59; ERBA2L; ERp59; GIT; Gltathione insulin transhydrogenase; Glutathione insulin transhydrogenase; P4HB; P4Hbeta; p55; PDI; PDIA1; PDIA1_HUMAN; PDIR; PHDB; PO4DB; PO4HB; Procollagen proline 2 oxoglutarate 4 dioxygenase (proline 4 hydroxylase) beta polypeptide (protein disulfide isomerase associated 1); Procollagen proline 2 oxoglutarate 4 dioxygenase beta subunit; PROHB; Prolyl 4 hydroxylase beta polypeptide; Prolyl 4 hydroxylase beta subunit; Prolyl 4 hydroxylase subunit beta; Prolyl 4-hydroxylase subunit beta; Protein disulfide isomerase associated 1; Protein disulfide isomerase, family A, member 1; Protein disulfide isomerase/oxidoreductase; Protein disulfide-isomerase; Protocollagen hydroxylase; Thbp; Thyroid hormone binding protein p55 ; Thyroid hormone binding protein p55 cellular; V erb a avian erythroblastic leukemia viral oncogene homolog 2 like
Datasheet & Coa
Please contact us to get it.
Expression Region
19-508aa
Mol. Weight
56.6 kDa
Protein Length
Partial
Purity
>95% as determined by SDS-PAGE.
Research Area
Signal Transduction
Source
E.Coli
Species
Homo sapiens (Human)
Target Names
Uniprot No.

Target Background

Function
This multifunctional protein plays a crucial role in the formation, breakage, and rearrangement of disulfide bonds. At the cell surface, it functions as a reductase, cleaving disulfide bonds of proteins attached to the cell. This process potentially modifies the structure of exofacial proteins. Within the cell, it participates in the formation and rearrangement of disulfide bonds in nascent proteins. At high concentrations, it acts as a chaperone, preventing aggregation of misfolded proteins. Conversely, at low concentrations, it facilitates aggregation (anti-chaperone activity). This protein may collaborate with other chaperones in the structural modification of the TG precursor during hormone biogenesis. Furthermore, it serves as a structural subunit of various enzymes, including prolyl 4-hydroxylase and microsomal triacylglycerol transfer protein (MTTP). It also functions as a receptor for LGALS9, an interaction that retains P4HB at the cell surface of Th2 T helper cells. This retention enhances disulfide reductase activity at the plasma membrane, altering the plasma membrane redox state and promoting cell migration.
Gene References Into Functions
  1. Peroxynitrite preferentially oxidizes the dithiol redox motifs of protein-disulfide isomerase. PMID: 29191937
  2. Overexpression of HIF-1alpha and P4HB is associated with poor prognosis in patients with gastric cancer. PMID: 29904245
  3. Studies have demonstrated that the expression of P4HB is frequently upregulated at the mRNA and protein levels in diffuse gliomas. Its high expression was significantly correlated with high Ki-67, more TP53 mutations, and poor survival outcome. These findings suggest that high expression of P4HB plays a significant role in diffuse glioma progression. PMID: 29207176
  4. Researchers have identified a potent and selective PDIA1 inhibitor, KSC-34, with 30-fold selectivity for the a site over the a' site. KSC-34 exhibits time-dependent inhibition of PDIA1 reductase activity in vitro with a kinact/ KI of 9.66 x 10(3) M(-1) s(-1). This inhibitor displays selectivity for PDIA1 over other members of the PDI family and other cellular cysteine-containing proteins. PMID: 29521097
  5. P4HB promotes hepatocellular carcinoma progression by down-regulating GRP78 expression and subsequently promoting epithelial-to-mesenchymal transition. PMID: 28052026
  6. Analysis has revealed the antiplatelet activity of CxxC through binding to Cys400 in the PDI a0 domain, which can be further utilized as a model for site-driven antithrombotic agent development. PMID: 28109047
  7. Current findings indicate that thiol isomerase-mediated disulfide bond modification in receptors and plasma proteins constitutes an important layer of control for thrombosis and vascular function more generally. PMID: 28598864
  8. DIA1 was robustly secreted by physiological levels of arterial laminar shear in endothelial cells and supported alpha 5 integrin thiol oxidation. PMID: 28034831
  9. Kinetic-based trapping by intervening sequence variants of the active sites of protein-disulfide isomerase identifies platelet protein substrates. PMID: 28364042
  10. Researchers have proposed a mechanism for dual Ero1alpha regulation through dynamic redox interactions between PDI and the two Ero1alpha flexible loops that harbor the regulatory cysteines. PMID: 27703014
  11. Analysis has investigated how redox affects human protein disulfide isomerase to regulate the binding affinity of 17 beta-estradiol. PMID: 28257787
  12. These findings enhance our understanding of PDI-protected aggregation of wild-type alpha-Syn and its H50Q familial mutant. PMID: 27142583
  13. Association of P4HB polymorphisms with sporadic amyotrophic lateral sclerosis susceptibility in the Chinese Han population has been observed. PMID: 26000911
  14. Researchers examined the effect of the endoplasmic reticulum chaperone protein disulfide isomerase (PDI) on beta-cell dysfunction. PMID: 26607804
  15. Amyotrophic lateral sclerosis-linked PDIA1 mutations disrupt motor neuron connectivity. PMID: 26869642
  16. Direct binding of PDIA1 to VWF has been reported. PMID: 26670633
  17. Selective sequestration of PDI1A in a calcium depletion-mediated complex with the abundant chaperone calreticulin attenuates the effective concentration of this major lumenal thiol oxidant. PMID: 25575667
  18. Cole-Carpenter syndrome is caused by a specific de novo mutation in P4HB that impairs the disulfide isomerase activity of protein disulfide isomerase. PMID: 25683117
  19. PDI plays a role as a competent regulator and a specific substrate of Ero1alpha, governing efficient and faithful oxidative protein folding and maintaining ER redox homeostasis. PMID: 25258311
  20. The crystal structure of the dimeric form of noncatalytic bb' domains of human PDIA1 determined to 2.3 A resolution revealed that the formation of dimers occludes the substrate binding site. PMID: 24549644
  21. Elevated P4HB expression is associated with temozolomide resistance in malignant glioma. PMID: 23444257
  22. The results suggest that P4HB is a modifier gene in amyotrophic lateral sclerosis susceptibility and may represent a potential therapeutic target for amyotrophic lateral sclerosis. PMID: 23337974
  23. A mixed disulfide complex was formed with the catalytic domain A1 from human PDI consistent with a model for cotranslational oxidative protein folding wherein PDI acts as a placeholder that is relieved by the pairing of cysteines caused by substrate folding. PMID: 23141538
  24. TPM4, PDIA, and SRC8 were also localized to the trophoblast cells, further highlighting the importance of these cytoskeletal remodeling proteins in early pregnancy. PMID: 21373848
  25. These data revealed a redox-regulated chaperone function of PDI in delivering antigenic peptides from TAP to MHC-I. PMID: 21299467
  26. Functional PDI is rapidly secreted from human umbilical vein endothelial cells in culture upon activation with thrombin or after laser-induced stimulation. PMID: 20668226
  27. Domain c is required for the stabilization and maintenance of the chaperone function of PDI under extreme conditions. PMID: 15358778
  28. Data indicate that binding sites in three PDI domains, a, b', and a', contribute to efficient C-P4H tetramer assembly. PMID: 15590633
  29. PDI can be S-nitrosated, and PDI-SNO can be denitrosated by PDI, suggesting that this enzyme could be intimately involved in the transport of intracellular NO equivalents to the cell surface. PMID: 15611098
  30. Data show that protein disulfide isomerase can switch its conformation from dimer to tetramer in its functions as a foldase. PMID: 15695804

Show More

Hide All

Database Links

HGNC: 8548

OMIM: 112240

KEGG: hsa:5034

STRING: 9606.ENSP00000327801

UniGene: Hs.464336

Involvement In Disease
Cole-Carpenter syndrome 1 (CLCRP1)
Protein Families
Protein disulfide isomerase family
Subcellular Location
Endoplasmic reticulum. Endoplasmic reticulum lumen. Melanosome. Cell membrane; Peripheral membrane protein.

Q&A

What is the molecular structure of recombinant Human P4HB?

Recombinant Human P4HB is a 56-60 kDa protein comprising 491 amino acids (mature form spans Asp18-Lys505). The protein contains two thioredoxin (TRX) domains located at amino acids 25-134 and 368-475, plus an endoplasmic reticulum (ER) retention sequence at amino acids 505-508 . When produced recombinantly, the protein is often tagged (e.g., with a C-terminal 10-His tag) to facilitate purification without compromising its catalytic activity . The protein exhibits high structural conservation across species, with human P4HB sharing approximately 94% amino acid identity with mouse P4HB over amino acids 18-505 .

What are the primary biochemical functions of P4HB in cellular contexts?

P4HB exhibits multiple distinct biochemical functions that vary by cellular location:

LocationFunctionMechanismSignificance
Endoplasmic ReticulumDisulfide bond formationCatalyzes formation, breakage, and rearrangement of disulfide bondsCritical for proper protein folding
Endoplasmic ReticulumChaperone activityInhibits aggregation of misfolded proteins at high concentrationsQuality control mechanism
Endoplasmic ReticulumAnti-chaperone activityFacilitates aggregation at low concentrationsRegulation of protein turnover
Cell SurfaceReductase activityCleaves disulfide bonds of cell-attached proteinsModifies exofacial protein structure
IntracellularSubunit of prolyl 4-hydroxylaseForms tetrameric complex with P4H alpha chainsEnables hydroxylation of proline in collagen

This multifunctionality makes P4HB a critical protein in cellular proteostasis and extracellular matrix formation .

What expression systems are optimal for producing functional recombinant P4HB?

Different expression systems yield recombinant P4HB with varying characteristics:

Expression SystemAdvantagesLimitationsPurityApplications
Escherichia coliHigh yield, cost-effective, simpler purificationPotential lack of post-translational modifications>95%SDS-PAGE, Western blot, functional studies
Chinese Hamster Ovary (CHO)Mammalian post-translational modifications, proper foldingHigher cost, more complex purification>80%Enzymatic assays requiring authentic activity

How should recombinant P4HB be stored to maintain optimal activity?

Proper storage is crucial for maintaining P4HB activity. The protein should be stored in appropriate buffer conditions, typically containing:

  • Tris buffer

  • NaCl

  • Glycerol as a cryoprotectant

Storage recommendations include:

  • Use a manual defrost freezer and avoid repeated freeze-thaw cycles

  • Store at -20°C to -70°C for up to 6 months from the receipt date

  • Once opened, maintain sterile conditions and store at -20°C to -70°C for up to 3 months

For experiments requiring consistent activity measurements, it's advisable to prepare single-use aliquots to prevent activity loss from repeated freeze-thaw cycles.

How can researchers effectively measure the disulfide isomerase activity of P4HB?

Quantifying P4HB's disulfide isomerase activity requires specialized assays that monitor the protein's ability to catalyze disulfide bond formation, breakage, or rearrangement:

  • RNase A refolding assay: This classical method measures P4HB's ability to restore activity to reduced and denatured RNase A by facilitating correct disulfide bond formation. The refolded RNase A activity is monitored spectrophotometrically using RNA or synthetic substrates.

  • Di-eosin-glutathione disulfide (di-E-GSSG) assay: A fluorescence-based approach where P4HB-catalyzed reduction of di-E-GSSG results in increased fluorescence as the eosin molecules are separated.

  • Insulin turbidity assay: Measures P4HB's reductase activity by monitoring the precipitation of reduced insulin chains, detected as an increase in solution turbidity at 650 nm.

For comparative studies, researchers should standardize their assay conditions, including temperature (typically 25°C or 37°C), pH (optimally 7.0-7.5), and substrate concentrations .

What experimental approaches can distinguish between P4HB's enzymatic and chaperone functions?

Differentiating between P4HB's enzymatic disulfide isomerase activity and its chaperone function requires carefully designed experiments:

  • Active site mutations: Generate recombinant P4HB with mutations in the CXXC motifs of the thioredoxin domains to eliminate enzymatic activity while potentially preserving chaperone function.

  • Concentration-dependent studies: Exploit the observation that P4HB exhibits chaperone activity at high concentrations but anti-chaperone activity at low concentrations. Design experiments with varied P4HB concentrations and measure protein aggregation using light scattering or centrifugation techniques .

  • Phosphorylation studies: Investigate how phosphorylation by FAM20C enhances P4HB's chaperone activity using either phosphomimetic mutations or in vitro phosphorylation systems.

  • Chemical inhibition: Utilize specific PDI inhibitors such as PACMA 31, an irreversible inhibitor that preferentially targets the enzymatic function, allowing researchers to isolate the chaperone activity .

How does P4HB contribute to collagen biosynthesis as part of the prolyl 4-hydroxylase complex?

P4HB serves as the beta subunit (also called the PDI subunit) of prolyl 4-hydroxylase (P4H), forming a tetrameric α₂β₂ complex with the alpha subunits. To study this function:

  • Reconstitution experiments: Combine purified recombinant P4HB with alpha subunits to form the active P4H tetramer in vitro. Measure hydroxylation activity using synthetic collagen peptides containing proline residues.

  • Co-immunoprecipitation studies: Use antibodies against P4HB to pull down the entire P4H complex from cellular lysates, followed by mass spectrometry to identify interacting partners and post-translational modifications.

  • Oxygen consumption assays: Since P4H is an oxygen-dependent enzyme, measure oxygen consumption rates as an indicator of hydroxylation activity.

  • Ascorbate dependency: P4H requires ascorbate (vitamin C) as a cofactor, and researchers can manipulate ascorbate levels to modulate P4H activity in experimental systems .

What control experiments are essential when studying P4HB in cellular systems?

Robust experimental designs for P4HB studies should incorporate these controls:

  • Catalytically inactive mutants: Compare wild-type P4HB with active-site mutants (typically mutations in the CXXC motifs) to distinguish between enzymatic and structural roles.

  • Dose-response experiments: Include multiple concentrations of P4HB to account for its concentration-dependent switch between chaperone and anti-chaperone activities .

  • Subcellular localization controls: Use compartment-specific markers alongside P4HB to distinguish between its ER and cell surface functions.

  • Species-specific considerations: When extrapolating between models, account for the 6% sequence difference between human and mouse P4HB (amino acids 18-505) .

  • Post-translational modification status: Verify the phosphorylation state of P4HB, particularly when studying its chaperone function, which is enhanced by FAM20C-mediated phosphorylation .

How can researchers effectively study P4HB's role at the cell surface versus its intracellular functions?

P4HB performs distinct functions in different cellular locations. To study location-specific functions:

  • Cell surface biotinylation: Use membrane-impermeable biotinylation reagents to selectively label and isolate cell surface P4HB for functional studies.

  • ER retention sequence mutations: Generate P4HB constructs with mutations in the ER retention sequence (amino acids 505-508) to increase cell surface localization .

  • Live-cell imaging: Employ fluorescently tagged P4HB constructs with appropriate controls to visualize its trafficking between compartments.

  • Receptor interaction studies: Investigate P4HB's interaction with LGALS9 at the cell surface of Th2 T helper cells, which retains P4HB at the plasma membrane and enhances cell migration through altered redox states .

How does P4HB contribute to viral infection mechanisms?

P4HB's cell surface reductase activity has implications for viral entry, particularly for HIV:

  • Viral entry assays: Measure viral entry efficiency in the presence of P4HB inhibitors or after P4HB knockdown/knockout.

  • Thiol-disulfide exchange monitoring: Employ redox-sensitive fluorescent probes to visualize P4HB-mediated reduction of viral disulfide bonds.

  • Cell-based fusion assays: Quantify the ability of P4HB to facilitate HIV fusion with CXCR4-expressing cells through its reduction of viral disulfide bonds .

This research area has potential therapeutic implications, as targeting P4HB might represent a novel approach to preventing viral entry.

What experimental designs are appropriate for studying the role of P4HB in disease models?

P4HB has been implicated in various pathological conditions, including Cole-Carpenter Syndrome. Researchers can employ:

  • Patient-derived cells: Compare P4HB expression, localization, and activity in cells from affected individuals versus controls.

  • CRISPR/Cas9 gene editing: Introduce disease-associated mutations into cellular models to study their effects on P4HB function.

  • Animal models: Develop conditional knockout or knockin mouse models to study tissue-specific effects of P4HB alterations.

  • Proteostasis challenges: Expose cells with altered P4HB function to ER stress inducers to assess changes in the unfolded protein response pathways.

  • High-throughput compound screening: Identify modulators of P4HB activity that could potentially correct disease-associated defects in protein folding .

What statistical approaches are recommended for analyzing P4HB activity data?

When analyzing P4HB activity data, researchers should consider:

  • Enzyme kinetics modeling: Apply Michaelis-Menten or more complex enzyme kinetics models to determine parameters such as Km and Vmax for different substrates.

  • Concentration-dependent effects analysis: Use non-linear regression to analyze the biphasic effects of P4HB concentration on protein aggregation.

  • Comparative activity analysis: Employ ANOVA with appropriate post-hoc tests when comparing wild-type versus mutant P4HB activity or P4HB from different sources.

  • Time-course experiments: Apply repeated measures analysis for time-dependent changes in P4HB activity.

  • Active learning approaches: For complex experimental designs with multiple variables, consider advanced machine learning techniques for experimental design optimization as described in computational biology research3.

How can researchers optimize experimental design when studying complex P4HB interactions?

When investigating P4HB's multiple functions and interactions:

This methodological approach ensures efficient use of resources while maximizing the information gained from each experiment, particularly important when working with recombinant proteins that may be costly or challenging to produce in large quantities.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.